Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Per Albertsson

Showing results (21-30 of 110) with videos related to

Pageof 11
Sort By:
Acta Oncologica (Stockholm, Sweden)|November 3, 2022
Societal costs of ovarian cancer in a population-based cohort - a cost of illness analysisCharlotte Palmqvist, Josefine Persson, Per Albertsson, et al.
Cancer Chemotherapy and Pharmacology|December 8, 2005
The anti-tumour effect of low-dose continuous chemotherapy may partly be mediated by thrombospondinJan-Erik Damber, Christina Vallbo, Per Albertsson, et al.
European Journal of Cardio-Thoracic Surgery : Official Journal of the European Association for Cardio-Thoracic Surgery|February 1, 2014
Coronary artery bypass grafting-related bleeding complications in real-life acute coronary syndrome patients treated with clopidogrel or ticagrelorEmma C Hansson, Helena Rexius, Mikael Dellborg, et al.
Resuscitation|October 14, 2018
Comorbidity and survival in out-of-hospital cardiac arrestGeir Hirlekar, Martin Jonsson, Thomas Karlsson, et al.
BMC Cancer|May 4, 2017
Immunohistochemical evaluation of epithelial ovarian carcinomas identifies three different expression patterns of the MX35 antigen, NaPi2bKristina Levan, Matin Mehryar, Constantina Mateoiu, et al.
Scientific Reports|November 6, 2019
Towards elucidating the radiochemistry of astatine - Behavior in chloroformEmma Aneheim, Stig Palm, Holger Jensen, et al.
Cancer Biotherapy & Radiopharmaceuticals|February 21, 2020
Realizing Clinical Trials with Astatine-211: The Chemistry InfrastructureSture Lindegren, Per Albertsson, Tom Bäck, et al.
Anticancer Research|September 21, 2012
A phase I study of concurrent chemoradiotherapy and cetuximab for locally advanced esophageal cancerCecilie Holländer, Lene Baeksgaard, Morten Sorensen, et al.
International Journal of Cardiology|January 28, 2009
Recurrent bare metal stent thrombosis: six years, single center experienceMichael Koutouzis, Per Albertsson, Dan Ioanes, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|January 16, 2016
Biokinetic Modeling and Dosimetry for Optimizing Intraperitoneal Radioimmunotherapy of Ovarian Cancer MicrotumorsStig Palm, Tom Bäck, Börje Haraldsson, et al.
Pageof 11

Showing results (21-30 of 110) with videos related to

Sort By:
Pageof 11
Acta Oncologica (Stockholm, Sweden)|November 3, 2022
Societal costs of ovarian cancer in a population-based cohort - a cost of illness analysisCharlotte Palmqvist, Josefine Persson, Per Albertsson, et al.
Cancer Chemotherapy and Pharmacology|December 8, 2005
The anti-tumour effect of low-dose continuous chemotherapy may partly be mediated by thrombospondinJan-Erik Damber, Christina Vallbo, Per Albertsson, et al.
European Journal of Cardio-Thoracic Surgery : Official Journal of the European Association for Cardio-Thoracic Surgery|February 1, 2014
Coronary artery bypass grafting-related bleeding complications in real-life acute coronary syndrome patients treated with clopidogrel or ticagrelorEmma C Hansson, Helena Rexius, Mikael Dellborg, et al.
Resuscitation|October 14, 2018
Comorbidity and survival in out-of-hospital cardiac arrestGeir Hirlekar, Martin Jonsson, Thomas Karlsson, et al.
BMC Cancer|May 4, 2017
Immunohistochemical evaluation of epithelial ovarian carcinomas identifies three different expression patterns of the MX35 antigen, NaPi2bKristina Levan, Matin Mehryar, Constantina Mateoiu, et al.
Scientific Reports|November 6, 2019
Towards elucidating the radiochemistry of astatine - Behavior in chloroformEmma Aneheim, Stig Palm, Holger Jensen, et al.
Cancer Biotherapy & Radiopharmaceuticals|February 21, 2020
Realizing Clinical Trials with Astatine-211: The Chemistry InfrastructureSture Lindegren, Per Albertsson, Tom Bäck, et al.
Anticancer Research|September 21, 2012
A phase I study of concurrent chemoradiotherapy and cetuximab for locally advanced esophageal cancerCecilie Holländer, Lene Baeksgaard, Morten Sorensen, et al.
International Journal of Cardiology|January 28, 2009
Recurrent bare metal stent thrombosis: six years, single center experienceMichael Koutouzis, Per Albertsson, Dan Ioanes, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|January 16, 2016
Biokinetic Modeling and Dosimetry for Optimizing Intraperitoneal Radioimmunotherapy of Ovarian Cancer MicrotumorsStig Palm, Tom Bäck, Börje Haraldsson, et al.
Pageof 11